PA
NARI

PharVision Advisers’s Inari Medical, Inc. Common Stock NARI Stock Holding History

PharVision Advisers’s Portfolio NARI Stock Details NARI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-4,062
Closed -$207K – 545
2024
Q4 		$207K Buy
+4,062
New +$200K 0.18% 287

Other funds holding NARI

SA
SoundView Advisors Olympia, Washington $281M AUM 17.96% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
TCWM
Total Clarity Wealth Management St. Charles, Illinois $515M AUM 27.37% 1-Year Est. Return
PS
Principal Securities Des Moines, Iowa $6.82B AUM 17.15% 1-Year Est. Return

PharVision Advisers's NARI Position: Q1 2025 in Review

PharVision Advisers sold out of Inari Medical, Inc. Common Stock (NARI) in Q1 2025, closing a stake of 4,062 shares — an estimated $207K sold.

PharVision Advisers first reported a position in NARI in Q4 2024 and held it in 1 quarter. The position peaked at $207K in Q4 2024. 4 funds tracked by Wall St. Rank hold NARI as of Q1 2025.

  • PharVision Advisers reported no remaining Inari Medical, Inc. Common Stock position as of Q1 2025 after selling out during the quarter.
  • PharVision Advisers sold 4,062 Inari Medical, Inc. Common Stock shares in Q1 2025, an estimated $207K.
  • PharVision Advisers first reported a position in Inari Medical, Inc. Common Stock in Q4 2024 and held it in 1 quarter.
  • PharVision Advisers's Inari Medical, Inc. Common Stock position peaked at $207K in Q4 2024.
  • 4 funds tracked by Wall St. Rank held Inari Medical, Inc. Common Stock as of Q1 2025.

Based on PharVision Advisers's 13F filing for Q1 2025, filed 15 May 2025.